Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
NCT ID: NCT05936242
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2021-05-18
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Blood samples and anthropometrics will be collected during hospital visit. Participants will be asked to:
* record a seven-day food diary
* complete EPIC food frequency questionnaire
* complete questionnaires on sleep hygiene
* collect a stool sample
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740
Individualised Postprandial Glucose Responses in Type 1 Diabetes
NCT05231642
Fats And Carbohydrates Quality on Postprandial glycemIc Response in Type 1 Diabetes
NCT02330939
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946
Pizza Leavening and Postprandial Glycemia in Type 1 Diabetes (LEAVEN)
NCT03619031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with T1D regularly attending the diabetes outpatient clinic of Federico II University Teaching Hospital, will be recruited. Participants' eating habits will be collected through a 7-day food record and the European Prospective Investigation into Cancer and Nutrition (EPIC) questionnaire. Fasting blood samples will be collected for the evaluation of serum short-chain fatty acids, zonulin, metabolomic, and epigenetics. Moreover, participants will be asked to collect at home a faecal sample to determine gut microbiota composition (16s RNA sequencing). Patients will be asked to complete web-based questionnaires on sleep hygiene (Pittsburgh Sleep Quality Index, Epworth).
Postprandial glucose response will be assessed by data derived from continuous glucose monitoring (CGM) used for clinical care.
The association between the PGR, calculated as incremental AUC using the trapezoidal method, and gut microbiota composition will be assessed. Moreover, the association between PGR, dietary composition, metabolomics and epigenetics will be investigated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Other chronic or acute diseases
* Use of antibiotics in the past 3 months
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rivellese angela
Professor, Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federico II University Hospital
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Abuqwider J, Salamone D, Scida G, Corrado A, Costabile G, Luongo D, Annuzzi G, Rivellese A, Bozzetto L. Sex-specific associations of serum short-chain fatty acids with glycaemic control: an Italian cross-sectional study in adults with type 1 diabetes. BMJ Open. 2025 Mar 24;15(3):e096994. doi: 10.1136/bmjopen-2024-096994.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Prot. 338/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.